The history of Viagra, formerly marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical sector. While its early success and generation of billions in earnings , the intellectual property lapse has opened the way for alternative medications, greatly reducing profit prospects . This transition raises questi